An shRNA screen in primary human beta cells identifies the serotonin 1F receptor as a negative regulator of survival during transplant

Rebecca A. Lee,Deeksha G. Chopra,Vinh Nguyen,Xi-Ping Huang,Yaohuan Zhang,Kaavian Shariati,Nicholas Yiv,Rebecca Schugar,Justin Annes,Bryan Roth,Gregory M. Ku

DOI: https://doi.org/10.1101/2024.05.01.591950

2024-05-03

Abstract:Islet transplantation can cure type 1 diabetes, but peri-transplant beta cell death limits this procedure to those with low insulin requirements. Improving human beta cell survival or proliferation may make islet transplantation a possibility for more type 1 patients. To identify novel regulators of beta cell survival and proliferation, we conducted a pooled small hairpin RNA (shRNA) screen in primary human beta cells transplanted into immunocompromised mice. shRNAs targeting several cyclin dependent kinase inhibitors were enriched after transplant. Here, we focused on the Gi/o-coupled GPCR, serotonin 1F receptor ( 5-HT ) which our screen identified as a negative regulator of beta cell numbers after transplant. , 5-HT knockdown induced human beta cell proliferation but only when combined with harmine and exendin-4. , knockdown of 5-HT reduced beta cell death during transplant. To demonstrate the feasibility of targeting 5-HT in islet transplant, we identified and validated a small molecule 5-HT antagonist. This antagonist increased glucose stimulated insulin secretion from primary human islets and cAMP accumulation in primary human beta cells. Finally, the 5-HT antagonist improved glycemia in marginal mass, human islet transplants into immunocompromised mice. We identify 5-HT as a novel druggable target to improve human beta cell survival in the setting of islet transplantation.

Cell Biology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is: how to improve the survival rate of β - cells after human islet transplantation, thereby improving the treatment effect for type 1 diabetes patients.

Specifically, through a series of experiments, the authors aimed to identify and verify the key regulatory factors that affect the survival and proliferation of human β - cells. They found that the 5 - hydroxytryptamine 1F receptor (5 - HT1F) is a new negative regulatory factor, which inhibits the survival and function of β - cells during the transplantation process. By knocking down or antagonizing 5 - HT1F, β - cell death can be reduced, its survival rate can be increased, and blood - glucose control after transplantation can be improved.

### Summary of main research questions:
1. **Improving the survival rate of β - cells**: Many β - cells die soon after transplantation, which limits the application scope of islet transplantation. Therefore, finding methods that can improve the survival rate of β - cells is crucial for expanding the application of islet transplantation.
2. **Identifying new regulatory factors**: Through shRNA screening, the authors hope to find new molecular targets that regulate the survival and proliferation of β - cells.
3. **Verifying the role of 5 - HT1F**: Determine whether 5 - HT1F is a negative regulatory factor for β - cell survival and explore the feasibility of it as a drug target.

### Key findings:
- **5 - HT1F negatively regulates β - cell survival**: Through shRNA screening, the authors found that 5 - HT1F is a negative regulatory factor, and its knockdown can reduce β - cell death and improve the survival rate.
- **Effect of 5 - HT1F antagonists**: The authors identified and verified a small - molecule 5 - HT1F antagonist, which can increase glucose - stimulated insulin secretion and improve blood - glucose control after transplantation.
- **Potential clinical applications**: These findings provide a basis for developing new drug targets and may help improve the success rate of human islet transplantation.

Through these studies, the authors not only revealed the mechanism of action of 5 - HT1F in β - cells, but also provided theoretical and technical support for the development of new treatment methods in the future.